ARDEA BIOSCIENCES, INC./DE Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-05-07: Reporting owner TANG KEVIN C | TANG CAPITAL MANAGEMENT LLC | TANG CAPITAL PARTNERS LP; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2008-05-07: Reporting owner BAKER FELIX | Baker Bros. Capital (GP), LLC | BAKER JULIAN; Form 4; Security Series A Convertible Preferred; Transaction C Conversion of derivative security.
- 2008-05-07: Reporting owner BAKER JULIAN | BAKER FELIX | Baker Biotech Capital (GP), LLC; Form 4; Security Series A Convertible Preferred; Transaction C Conversion of derivative security.
- 2008-05-07: Reporting owner Baker Brothers Life Sciences Capital (GP), LLC | BAKER FELIX | BAKER JULIAN; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-05-07 | TANG KEVIN C | TANG CAPITAL MANAGEMENT LLC | TANG CAPITAL PARTNERS LP Director, 10% Owner | 10% Owner | 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · By LP | C Conversion of derivative security | −162 0 owned after | $0.00 | 2008-05-16 | |
| 2008-05-07 | BAKER FELIX | Baker Bros. Capital (GP), LLC | BAKER JULIAN 10% Owner | 10% Owner | 10% Owner | 4 | Series A Convertible Preferred Derivative · Indirect · Through Partnership | C Conversion of derivative security | −11 0 owned after | $0.00 | 2008-05-16 | |
| 2008-05-07 | BAKER JULIAN | BAKER FELIX | Baker Biotech Capital (GP), LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series A Convertible Preferred Derivative · Indirect · Through Partnership | C Conversion of derivative security | −56 0 owned after | $0.00 | 2008-05-16 | |
| 2008-05-07 | Baker Brothers Life Sciences Capital (GP), LLC | BAKER FELIX | BAKER JULIAN 10% Owner | 10% Owner | 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · Through Partnership | C Conversion of derivative security | −63 0 owned after | $0.00 | 2008-05-16 | |
| 2008-05-07 | BAKER JULIAN | Baker / Tisch Capital (GP), LLC | BAKER FELIX 10% Owner | 10% Owner | 10% Owner | 4 | Series A Convertible Preferred Derivative · Indirect · Through Partnership | C Conversion of derivative security | −8 0 owned after | $0.00 | 2008-05-16 |